Picture of medmix AG logo

MEDX — medmix AG News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Brief: Medmix AG Says In H1, Revenue Of CHF 241.2 Mln, 2.8% Lower Y-o-Y

July 18 (Reuters) - medmix AG  MEDX.S :
    * IN H1, REVENUE OF CHF 241.2 MILLION, 2.8% LOWER
YEAR-ON-YEAR
    * FULL-YEAR 2024 GUIDANCE REDUCED TO REFLECT ONGOING
SOFTNESS IN
END MARKETS
    * H1 ADJUSTED EBITDA AT CHF 46.0 MILLION, DECREASE OF -7.4%
YEAR-ON-YEAR
    * SEES FY ADJUSTED EBITDA MARGIN OF 18% TO 19% (VERSUS. "AT
LEAST
20%" PREVIOUSLY AND 19.1% ACTUAL IN FY 2023)
    * SEES FY ORGANIC REVENUE GROWTH RATE FLAT TO NEGATIVE
(VERSUS.
"+4% TO +6%" PREVIOUSLY AND +1.1% ACTUAL IN FY 2023)

Source text for Eikon:  ID: 
Further company coverage:  MEDX.S 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on medmix AG

See all news